Externally used traditional Chinese medicine for treating rheumatoid arthritis

Abstract

The invention provides an externally used traditional Chinese medicine for treating rheumatoid arthritis, which is prepared by a main drug and mineral water. The main drug consists of bulk drugs including, by weight, from 3 to 5 parts of thunder god vine, from 0.5 to 1.5 parts of goldthread, from 1 to 3 parts of frankincense, from 3 to 5 parts of semen strychni, from 1 to 2 parts of hagworm, from1 to 3 parts of myrrh, from 1.5 to 2.5 parts of hindu datura flowers, from 2 to 4 parts of monkshood, from 0.3 to 0.7 part of cantharides, from 1 to 2 parts of nidus vespae, from 2 to 7 parts of radix aconiti agrestis, from 0.1 to 0.2 part of musk, from 3 to 5 parts of rhizoma arisaematis, from 0.5 to 1.5 parts of centipede, from 0.1 to 0.2 part of bezoar, from 1 to 3 parts of rhizoma typhonii, from 1 to 3 parts of clove and from 0.5 to 1.5 parts of scorpio. The utilization quantity of the mineral water is 150-250 parts by volume, and when the unit of the weight of the main drug is gram, the unit of the volume of the mineral water is millimeter correspondingly. The externally used traditional Chinese medicine for treating rheumatoid arthritis has the advantages of safety, effectiveness, speediness, easiness in operation and high economical efficiency.

Description

technical field [0001] The invention relates to an external Chinese medicine, in particular to an external Chinese medicine for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease mainly characterized by joint disease. The main clinical manifestation is symmetrical polyarthritis, with the joints of the hands, wrists, and feet most commonly involved. In the early stage, redness, swelling, heat, pain, and dyskinesia are the main symptoms. In the late stage, joint stiffness and deformity can be seen. The disease incidence rate is higher, generally about 1% in foreign countries, and 0.1%-0.3% in my country. The incidence is mostly in young adults, and the age of onset of 80% of patients is about 20-45 years old. According to statistics, the disability rate of this disease is as high as 60-70%, and 10% of them lose their labor force within several years, seriously endangering the health of the general pe...

AI Technical Summary

Problems solved by technology

The drug can only play an anti-inflammatory and analgesic role, and cannot reduce or alleviate the destructive lesions of articular cartilage and bone joints, let alone inhibit the progress of the disease. Long-term use can lead to severe gastrointestinal side effects

(2) Slow-acting rheumatic drugs mainly include: antisymptomatic agents, gold preparations, penicillamine, and azosulfapyridine; immunosuppressants: methotrexate, cyclophosphamide, azathioprine, cyclosporine, leflu Meite et al. have the effect of suppressing the immune response and can change the course of rheumatoid arthritis, but they cannot cure the disease, and they all have certain toxicity, which can lead to serious adverse reactions in patients.

(3) Glucocorticoids have powerful anti-inflammatory effects and certain immunosuppressive effects, and can improve symptoms of patients. However, the serious adverse reactions of glucocorticoids greatly limit their role in the treatment of rheumatoid arthritis. Commonly used drugs in clinical practice include prednisone and debronone, etc.

Images